Literature DB >> 23298640

The role of microRNAs in hepatocyte nuclear factor-4alpha expression and transactivation.

Zhongyan Wang1, Peter A Burke.   

Abstract

Hepatocyte nuclear factor (HNF)-4α is a key member of the transcription factor network regulating hepatocyte differentiation and function. Genetic and molecular evidence suggests that expression of HNF-4α is mainly regulated at the transcriptional level. Activation of HNF-4A gene involves the interaction of distinct sets of transcription factors and co-transcription factors within enhancer and promoter regions. Here we study the inhibitory effect of microRNAs (miRNAs) on the 3'-untranslated region (3'-UTR) of HNF-4A mRNA. The potential recognition elements of a set of miRNAs were identified utilizing bioinformatics analysis. The family members of miR-34 and miR-449, including miR-34a, miR-34c-5p and miR-449a, share the same target elements located at two distinct locations within the 3'-UTR of HNF-4A. The over-expression of miR-34a, miR-34c-5p or miR-449a in HepG2 cells led to a significant decrease in the activity of luciferase reporter carrying 3'-UTR of HNF-4A. The repressive effect on reporter activity was partially or fully eliminated when one or two of the binding site(s) for miR-34a/miR-34c-5p/miR-449a were deleted within the 3'-UTR. The protein level of HNF-4α was dramatically reduced by over-expression of miR-34a, miR-34c-5p and miR-449a, which correlates with a decrease in the binding activity of HNF-4α and transactivation of HNF-4α target genes. These results suggest that the recognition sites of miR-34a, miR-34c-5p and miR-449a within 3'-UTR of HNF-4A are functional. The mechanism of down-regulation of the binding activity and transactivation of HNF-4α by the miRNAs involves the decrease in HNF-4α protein level via miRNAs selectively targeting HNF-4A 3'-UTR, leading to the translational repression of HNF-4α expression.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23298640      PMCID: PMC3625485          DOI: 10.1016/j.bbagrm.2012.12.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  37 in total

1.  Combinatorial microRNA target predictions.

Authors:  Azra Krek; Dominic Grün; Matthew N Poy; Rachel Wolf; Lauren Rosenberg; Eric J Epstein; Philip MacMenamin; Isabelle da Piedade; Kristin C Gunsalus; Markus Stoffel; Nikolaus Rajewsky
Journal:  Nat Genet       Date:  2005-04-03       Impact factor: 38.330

Review 2.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

3.  CREB-binding protein is a transcriptional coactivator for hepatocyte nuclear factor-4 and enhances apolipoprotein gene expression.

Authors:  H Dell; M Hadzopoulou-Cladaras
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

4.  Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals.

Authors:  Xiaohui Xie; Jun Lu; E J Kulbokas; Todd R Golub; Vamsi Mootha; Kerstin Lindblad-Toh; Eric S Lander; Manolis Kellis
Journal:  Nature       Date:  2005-02-27       Impact factor: 49.962

5.  Effects of hepatocyte nuclear factor-4alpha on the regulation of the hepatic acute phase response.

Authors:  Zhongyan Wang; Peter A Burke
Journal:  J Mol Biol       Date:  2007-05-24       Impact factor: 5.469

6.  A microRNA component of the p53 tumour suppressor network.

Authors:  Lin He; Xingyue He; Lee P Lim; Elisa de Stanchina; Zhenyu Xuan; Yu Liang; Wen Xue; Lars Zender; Jill Magnus; Dana Ridzon; Aimee L Jackson; Peter S Linsley; Caifu Chen; Scott W Lowe; Michele A Cleary; Gregory J Hannon
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

7.  Modulation of hepatocyte nuclear factor-4alpha function by the peroxisome-proliferator-activated receptor-gamma co-activator-1alpha in the acute-phase response.

Authors:  Zhongyan Wang; Peter A Burke
Journal:  Biochem J       Date:  2008-10-15       Impact factor: 3.857

8.  SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4.

Authors:  Jen-Chywan Wang; John M Stafford; Daryl K Granner
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

Review 9.  Many roads to maturity: microRNA biogenesis pathways and their regulation.

Authors:  Julia Winter; Stephanie Jung; Sarina Keller; Richard I Gregory; Sven Diederichs
Journal:  Nat Cell Biol       Date:  2009-03       Impact factor: 28.824

10.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.

Authors:  Tsung-Cheng Chang; Erik A Wentzel; Oliver A Kent; Kalyani Ramachandran; Michael Mullendore; Kwang Hyuck Lee; Georg Feldmann; Munekazu Yamakuchi; Marcella Ferlito; Charles J Lowenstein; Dan E Arking; Michael A Beer; Anirban Maitra; Joshua T Mendell
Journal:  Mol Cell       Date:  2007-05-31       Impact factor: 17.970

View more
  12 in total

Review 1.  MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Authors:  Ai-Ming Yu; Ye Tian; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek
Journal:  Drug Metab Dispos       Date:  2015-11-13       Impact factor: 3.922

2.  Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans.

Authors:  Dianke Yu; Leihong Wu; Pritmohinder Gill; William H Tolleson; Si Chen; Jinchun Sun; Bridgett Knox; Yaqiong Jin; Wenming Xiao; Huixiao Hong; Yong Wang; Zhen Ren; Lei Guo; Nan Mei; Yongli Guo; Xi Yang; Leming Shi; Yinting Chen; Linjuan Zeng; Kostiantyn Dreval; Volodymyr Tryndyak; Igor Pogribny; Hong Fang; Tieliu Shi; Sandra McCullough; Sudeepa Bhattacharyya; Laura Schnackenberg; William Mattes; Richard D Beger; Laura James; Weida Tong; Baitang Ning
Journal:  Arch Toxicol       Date:  2017-10-24       Impact factor: 5.153

3.  hsa-miR-34a-5p Ameliorates Hepatic Ischemia/Reperfusion Injury Via Targeting HNF4α.

Authors:  Xiaoqiang Zheng; Gang Wang; Jiang Yuan; Nuoya Li; Biaolei Yan; Jinlong Yan; Yanling Sheng
Journal:  Turk J Gastroenterol       Date:  2022-07       Impact factor: 1.555

4.  Regulation of microRNA expression by rifampin in human hepatocytes.

Authors:  Anuradha Ramamoorthy; Yunlong Liu; Santosh Philips; Zeruesenay Desta; Hai Lin; Chirayu Goswami; Andrea Gaedigk; Lang Li; David A Flockhart; Todd C Skaar
Journal:  Drug Metab Dispos       Date:  2013-08-09       Impact factor: 3.922

5.  Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis.

Authors:  Raj Vuppalanchi; Tiebing Liang; Chirayu Pankaj Goswami; Rohit Nalamasu; Lang Li; David Jones; Rongrong Wei; Wanqing Liu; Vishal Sarasani; Sarath Chandra Janga; Naga Chalasani
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

Review 6.  MiRNAs and miRNA Polymorphisms Modify Drug Response.

Authors:  Mu-Peng Li; Yao-Dong Hu; Xiao-Lei Hu; Yan-Jiao Zhang; Yong-Long Yang; Chun Jiang; Jie Tang; Xiao-Ping Chen
Journal:  Int J Environ Res Public Health       Date:  2016-11-08       Impact factor: 3.390

7.  miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway.

Authors:  S-L Tung; W-C Huang; F-C Hsu; Z-P Yang; T-H Jang; J-W Chang; C-M Chuang; C-R Lai; L-H Wang
Journal:  Oncogenesis       Date:  2017-05-01       Impact factor: 7.485

8.  HNF-4 participates in the hibernation-associated transcriptional regulation of the chipmunk hibernation-related protein gene.

Authors:  Daisuke Tsukamoto; Michihiko Ito; Nobuhiko Takamatsu
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

9.  The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.

Authors:  Helena K Fritz; Anna Gustafsson; Börje Ljungberg; Yvonne Ceder; Håkan Axelson; Björn Dahlbäck
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

10.  MiRNA-Based Regulation of Hemostatic Factors through Hepatic Nuclear Factor-4 Alpha.

Authors:  Salam Salloum-Asfar; Ana B Arroyo; Raúl Teruel-Montoya; Nuria García-Barberá; Vanessa Roldán; Vicente Vicente; Constantino Martínez; Rocío González-Conejero
Journal:  PLoS One       Date:  2016-05-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.